Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $116,928 - $263,872
-22,400 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $53,700 - $83,800
10,000 Added 80.65%
22,400 $146,000
Q3 2021

Nov 12, 2021

SELL
$7.36 - $13.67 $92,000 - $170,875
-12,500 Reduced 50.2%
12,400 $91,000
Q2 2020

Aug 13, 2020

BUY
$3.53 - $6.17 $15,885 - $27,765
4,500 Added 22.06%
24,900 $135,000
Q1 2020

May 11, 2020

BUY
$3.53 - $12.21 $2,471 - $8,547
700 Added 3.55%
20,400 $82,000
Q4 2019

Feb 12, 2020

BUY
$11.58 - $17.37 $228,126 - $342,189
19,700 New
19,700 $228,000
Q3 2019

Nov 14, 2019

SELL
$13.91 - $19.87 $346,359 - $494,763
-24,900 Closed
0 $0
Q2 2019

Aug 20, 2019

BUY
$13.19 - $28.36 $328,431 - $706,164
24,900 New
24,900 $364,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.